Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,321,451 papers from all fields of science
Search
Sign In
Create Free Account
PF-477736
Known as:
PF-00477736
, PF477736
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
CHK1 Inhibitor PF-477736
PF 00477736
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Chk-mate on resistance to kinase inhibitors
P. Shapiro
OncoTarget
2018
Corpus ID: 52134236
The invariable development of drug resistance represents a major obstacle to the successful treatment of cancer with kinase…
Expand
2017
2017
Checkpoint kinase 1 inhibition sensitises transformed cells to dihydroorotate dehydrogenase inhibition
S. Arnould
,
G. Rodier
,
+14 authors
C. Sardet
OncoTarget
2017
Corpus ID: 54559878
Reduction in nucleotide pools through the inhibition of mitochondrial enzyme dihydroorotate dehydrogenase (DHODH) has been…
Expand
2015
2015
Synergism between bosutinib (SKI-606) and the Chk1 inhibitor (PF-00477736) in highly imatinib-resistant BCR/ABL⁺ leukemia cells.
Tri Nguyen
,
Elisa Hawkins
,
+4 authors
S. Grant
Leukemia research : a Forum for Studies on…
2015
Corpus ID: 23019100
2014
2014
Chk 1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers
C. Bryant
,
Rebecca Rawlinson
,
A. Massey
2014
Corpus ID: 19405811
Background: Chk1 inhibitors are currently in clinical trials as putative potentiators of cytotoxic chemotherapy drugs. Chk1…
Expand
2014
2014
Abstract 1600: Keeping glioblastoma (GBM)in check by targeting the CHK1-STAT3-CIP2A axis
A. Khanna
,
B. Stringer
,
+5 authors
J. Pimanda
2014
Corpus ID: 70527359
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Checkpoint kinase1 (CHK1) is a DNA damage kinase, which…
Expand
2014
2014
Abstract 2766: Inhibition of Chk1 and Wee1 as a new therapeutic approach in Mantle Cell Lymphoma
L. Carrassa
,
Rosaria Chilà
,
+8 authors
G. Damia
2014
Corpus ID: 70779800
Mantle Cell Lymphoma (MCL) is an aggressive lymphoma, for which there is not yet a standard therapy. Deregulation of cell cycle…
Expand
2013
2013
Investigating the predictors of sensitivity to the Chk1 inhibitor PF-00477736 in melanoma
B. Wicaksono
2013
Corpus ID: 78623839
2011
2011
Abstract 2549: Efficacy of the Chk1 inhibitor PF-00477736 and pemetrexed in human mesothelioma
A. Blasina
,
Jill Hallin
,
Wei Tan
,
G. Los
,
J. Jani
2011
Corpus ID: 71553140
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Malignant pleural mesothelioma (MPM) is a highly…
Expand
Highly Cited
2009
Highly Cited
2009
PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts
Cathy C. Zhang
,
Zhengming Yan
,
+13 authors
J. Christensen
Clinical Cancer Research
2009
Corpus ID: 2632946
Purpose: Checkpoint kinase 1 (Chk1) plays a critical role in the activation of mitotic spindle checkpoint and DNA damage…
Expand
2007
2007
Mechanisms of radiation enhancement by the CHK1 inhibitor PF-477736
C. Cullinane
,
J. Raleigh
,
K. Anderes
,
G. McArthur
2007
Corpus ID: 81534302
5386 CHK1 kinase is a key regulator of the S and G2 cell cycle checkpoints that are activated in response to DNA damage. Cell…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE